2012
DOI: 10.1016/j.copbio.2012.03.008
|View full text |Cite
|
Sign up to set email alerts
|

Bioengineering natural product biosynthetic pathways for therapeutic applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
35
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 37 publications
(35 citation statements)
references
References 66 publications
0
35
0
Order By: Relevance
“…The genome sequences of important Actinobacteria species reported to date indicate that as much as 90% of the chemical potential of these organisms remains undiscovered and that the biosynthetic machinery encoded by many of these genetic loci may be activatable under laboratory conditions (449). The predictive models of Watve et al (450) suggested that over 150,000 bioactive metabolites from members of the genus Streptomyces alone within this order are still waiting to be discovered (328,451).…”
Section: Actinobacteria As Sources Of Bioherbicide and Bioinsecticidementioning
confidence: 99%
“…The genome sequences of important Actinobacteria species reported to date indicate that as much as 90% of the chemical potential of these organisms remains undiscovered and that the biosynthetic machinery encoded by many of these genetic loci may be activatable under laboratory conditions (449). The predictive models of Watve et al (450) suggested that over 150,000 bioactive metabolites from members of the genus Streptomyces alone within this order are still waiting to be discovered (328,451).…”
Section: Actinobacteria As Sources Of Bioherbicide and Bioinsecticidementioning
confidence: 99%
“…3 The link between the sequence of the genes and the chemical structure of the product is particularly clear for pathways utilizing giant assembly-line synthases to produce complex reduced polyketides or nonribosomally-determined peptides. 4,5 However, there remain a number of valuable chemotypes whose biosynthetic pathways are obscure, and also many orphan clusters whose potentially novel products remain to be elucidated. Methods for systematic analysis of the entire complement of secondary metabolite biosynthetic gene clusters in a strain remain cumbersome and slow.…”
Section: Introductionmentioning
confidence: 99%
“…Engineering targeted changes in modular type I PKSs of prokaryotes generated small, focused libraries of conservative variants of selected bioactive scaffolds. However, these pioneering works with prokaryotic PKSs also yielded many unproductive combinations, suffered from greatly reduced product yields, and realized only a small fraction of the potential chemical space (28)(29)(30)(31).…”
Section: Significancementioning
confidence: 99%